Enochian BioSciences, Inc. announced on Monday that the Food and Drug Administration accepted a pre-investigational new drug request for a potential treatment for HIV.Pre-investigational new drug requests are very early stage communications between the Office of Infectious Diseases and creators of new treatments.
The company expects comments from the administration sometime this fall.Enochian Biosciences specializes in gene-modified cellular and immune therapies in infectious diseases and cancers.Dr.
Serhat Gumrukçu, co-founder of the company, submitted the request based on the findings of a 54-year-old man with HIV who achieved viral control for 255 days due to treatment with Natural Killer and Gamma Delta T-cells, according to a company.
Meaws.com provides you with the latest lgbt news worldwide. Gossips, photos and videos, exclusive interviews, breaking news from the rainbow world of queer people are waiting for you here. So, stay tuned and get to know who, where, when and with whom in the world of lgbt, happy and proud people. Are you eager to know first!? Then just follow us every day and we will offer you more and more!
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
©2022. All rights reserved.